Intermittent Androgen Castration: A Biological Reality during Intermittent Treatment in Metastatic Prostate Cancer?

Publisher： Karger

E-ISSN： 1423-0399|75|3|204-208

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.3, 2005-10, pp. : 204-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermittent Androgen Deprivation for Locally Advanced Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Long-Term Outcomes in Patients with Prostate Cancer Managed with Intermittent Androgen Suppression

By  

Urologia Internationalis, Vol. 73, Iss. 2, 2004-08 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 88, Iss. 1, 2011-12 ,pp. : 25-33

Karger

Access to resources Recommend Favorite

Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer

By  

Reviews on Recent Clinical Trials, Vol. 11, Iss. 4, 2016-10 ,pp. : 317-323

Bentham Science Publishers

Access to resources Recommend Favorite

Use and impact of intermittent versus continuous systemic treatment strategies in metastatic colorectal cancer in routine practice

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2791-2798

John Wiley & Sons Inc

Access to resources Recommend Favorite